Annual Revenue
N/A
December 31, 2023
Summary
- XTLB annual revenue is not available.
Performance
XTLB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Revenue
$162.00 K
NaN%
September 30, 2024
Summary
- As of February 6, 2025, XTLB quarterly revenue is $162.00 thousand
- XTLB quarterly revenue is now -91.90% below its all-time high of $2.00 million, reached on September 30, 2008.
Performance
XTLB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$162.00 K
NaN%
September 30, 2024
Summary
- As of February 6, 2025, XTLB TTM revenue is $162.00 thousand
- XTLB TTM revenue is now -97.27% below its all-time high of $5.94 million, reached on September 30, 2008.
Performance
XTLB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
XTLB Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
XTLB Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | at low | at high | at low | ||
5 y | 5-year | at high | at low | at high | at low | ||
alltime | all time | -91.9% | +109.8% | -97.3% | -100.0% |
XTL Biopharmaceuticals Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $162.00 K(-109.8%) | $162.00 K(>+9900.0%) |
Dec 2013 | - | -$1.66 M(-450.5%) | $0.00(-100.0%) |
Sep 2013 | - | $473.00 K(-7.6%) | $1.31 M(+11.0%) |
Jun 2013 | - | $512.00 K(-23.9%) | $1.19 M(+76.1%) |
Mar 2013 | - | $673.00 K(-296.2%) | $673.00 K(>+9900.0%) |
Dec 2012 | - | -$343.00 K(-200.0%) | $0.00(-100.0%) |
Sep 2012 | - | $343.00 K(-82.8%) | $343.00 K(-94.2%) |
Dec 2008 | $5.94 M(+554.9%) | - | - |
Sep 2008 | - | $2.00 M(+1.5%) | $5.94 M(+42.6%) |
Jun 2008 | - | $1.97 M(0.0%) | $4.17 M(+80.3%) |
Mar 2008 | - | $1.97 M(+771.7%) | $2.31 M(+307.4%) |
Dec 2007 | $907.00 K | - | - |
Sep 2007 | - | $226.00 K(+98.2%) | $567.00 K(+24.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2007 | - | $114.00 K(0.0%) | $455.00 K(0.0%) |
Mar 2007 | - | $114.00 K(+0.9%) | $455.00 K(0.0%) |
Dec 2006 | $454.00 K(-85.8%) | $113.00 K(-0.9%) | $455.00 K(-28.5%) |
Sep 2006 | - | $114.00 K(0.0%) | $636.00 K(-22.2%) |
Jun 2006 | - | $114.00 K(0.0%) | $817.00 K(-59.6%) |
Mar 2006 | - | $114.00 K(-61.2%) | $2.02 M(-37.1%) |
Dec 2005 | $3.20 M(-7.4%) | $294.00 K(-0.3%) | $3.21 M(-15.0%) |
Sep 2005 | - | $295.00 K(-77.6%) | $3.78 M(-13.1%) |
Jun 2005 | - | $1.32 M(+1.1%) | $4.35 M(+28.3%) |
Mar 2005 | - | $1.30 M(+51.3%) | $3.39 M(+14.9%) |
Dec 2004 | $3.45 M | $862.00 K(-0.2%) | $2.95 M(+41.3%) |
Sep 2004 | - | $864.00 K(+140.7%) | $2.09 M(+70.6%) |
Jun 2004 | - | $359.00 K(-58.4%) | $1.22 M(+41.6%) |
Mar 2004 | - | $864.00 K | $864.00 K |
FAQ
- What is the all time high annual revenue for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals TTM revenue?
- What is the all time high TTM revenue for XTL Biopharmaceuticals?
What is the all time high annual revenue for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual revenue is $5.94 M
What is XTL Biopharmaceuticals quarterly revenue?
The current quarterly revenue of XTLB is $162.00 K
What is the all time high quarterly revenue for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly revenue is $2.00 M
What is XTL Biopharmaceuticals TTM revenue?
The current TTM revenue of XTLB is $162.00 K
What is the all time high TTM revenue for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high TTM revenue is $5.94 M